Assessment of TP53, PTEN and AKT gene mutations in tongue squamous cell carcinoma and oral leukoplakia of smokers and non-smokers

Authors

DOI:

https://doi.org/10.5327/2525-5711.337

Keywords:

TP53, PTEN, AKT, Loss of Heterozygosity, Smoking behavior

Abstract

Oral Squamous Cell Carcinoma (OSCC) is the most common malignant tumor of the oral cavity. It can be preceded by Oral leukoplakia (OL), the most prevalent potentially malignant disorder, which presents a malignant transformation rate which varies from 1,1 to 40,8%, found most commonly in tongue lesions. Smoking is a well-established risk factor for both OL and OSCC. In this study we aimed to investigate loss of heterozygosity (LOH) as well as the frequency and patterns of the mutations in the PTEN, AKT and TP53 genes in OL and tongue squamous cell carcinoma (TSCC) samples of smokers and non-smokers patients. Tissue specimens were obtained from 73 patients: 35 cases of TSCC and 38 cases of high grade OL occurring in the lateral border of the tongue, and PTEN, AKT e TP53 gene mutations were investigated through Fluorescence In Situ Hybridization and genotyping. Differences between the genetic changes studied in the TP53, PTEN and AKT genes in smoking and non-smoking patients were detected. Changes in the TP53 gene did not occur significantly in the OL stage in either smoking or non-smoking patients, whereas changes in the PTEN gene were observed in both OL and OSCC, with a statistically significant difference between smokers and non-smokers. Furthermore, changes in the AKT gene did not occur with high frequency in either OL or carcinomas, regardless of smoking status, suggesting that disruptions in the critical PI3K pathway are primarily due to genetic changes in PTEN rather than in the AKT gene.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660

Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years. Oral Dis. 2021;27(8):1881-95. https://doi.org/10.1111/odi.13810

Chen H, Liu X, Jin Z, Gou C, Liang M, Cui Li, et al. A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma. Am J Cancer Res. 2018;8(8):1403-13. PMID: 30210912.

Martins F, Sousa SC, Santos E, Woo SB, Gallottini M. PI3K–AKT–mTOR pathway proteins are differently expressed in oral carcinogenesis. J Oral Pathol Med. 2016;45(10):746-52. https://doi.org/10.1111/jop.12440

Miyahara LAN, Pontes FSC, Burbano RMR, Conte Neto N, Guimarães DM, Fonseca FP, et al. PTEN allelic loss is an important mechanism in the late stage of development of oral leukoplakia into oral squamous cell carcinoma. Histopathology. 2018;72(2):330 8. https://doi.org/10.1111/his.13381

Kerdjoudj M, De La Torre RA, Arnouk H. Characterization of DJ-1, PTEN, and p Akt as prognostic biomarkers in the progression of oral squamous cell carcinoma. Cureus. 2023;15(1):e34436. https://doi.org/10.7759/cureus.34436

Sundberg J, Pandey S, Giglio D, Holmberg E, Kjeller G, Kovács A, et al. Expression of p53, p63, podoplanin and Ki 67 in recurring versus non recurring oral leukoplakia. Sci Rep. 2021;11:20781. https://doi.org/10.1038/s41598-021-99326-

Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloa P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. https://doi.org/10.1016/j.oraloncology.2005.12.014 2006;42(10):987-93.

Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Dis. 2021;27(8):1947-76. https://doi.org/10.1111/odi.13993

Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 1986;83(9):2934-8. https://doi.org/10.1073/pnas.83.9.2934

Calcagno DQ, Leal MF, Taken SS, Assumpção PP, Demachki S, Smith MAC, et al. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res. 2005;25(6B):4069-74. PMID: 16309200.

Hopman AH, Ramaekers FC, Raap AK, Beck JL, Devilee P, van der Ploeg M, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988;89(4):307-16. https://doi.org/10.1007/BF00500631

Starzyńska A, Sejda A, Adamska P, Marvaso G, Sakowicz-Burkiewicz M, Adamski Łukasz, et al. Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review. Arch Med Sci. 2020;17(1):207-17. https://doi.org/10.5114/aoms.2020.100780

Das D, Maitra A, Panda CK, Ghose S, Roy B, Sarin R, et al. Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivobuccal oral cancer. NPJ Genom Med. 2021;6(1):32. https://doi.org/10.1038/s41525-021-00195-8

Batta N, Pandey M. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol. 2019;17(1):198. https://doi.org/10.1186/s12957-019-1741-2

Hyodo T, Kuribayashi N, Fukumoto C, Komiyama Y, Shiraishi R, Kamimura R, et al. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications. Sci Rep. 2022;12(1):21695. https://doi.org/10.1038/s41598 022-25744-8

Nakagaki T, Tamura M, Kobashi K, Koyama R, Fukushima H, Ohashi T, et al. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing. Oncotarget. 2017;8(35):59113-22. https://doi.org/10.18632/oncotarget.19262

Kato VJO, Abreu MC, Kato AMB, Souza LL, Pontes FSC, Sant'anna CC, et al. Significance of P16INK4A expression and PTEN loss of heterozygosity in human papilloma virus-related oral squamous cell carcinoma. Anticancer Res. 2020;40(11):6355-66. https://doi.org/10.21873/anticanres.14656

Wang Y, Lin L, Xu H, Zhou Y, Dan H, Jiang L, et al. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population. J Oral Pathol Med. 2015;44(1):45-50. https://doi.org/10.1111/jop.12211

Yi KH, Lauring J. Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity. Oncotarget. 2016;7(4):4241-51. https://doi.org/10.18632/oncotarget.6648

Chaves FN, Bezerra TMM, Moraes DC, Costa SFS, Silva PGB, Alves APNN, et al. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma. Exp Mol Pathol. 2020;112:104341. https://doi.org/10.1016/j.yexmp.2019.104341

Guimarães LM, Diniz MG, Rogatto SR, Gomez RS, Gomes CC. The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis. J Oral Pathol Med. 2021;50(7):632-8. https://doi.org/10.1111/jop.13140

Downloads

Published

2025-08-22

How to Cite

1.
Pereira GG, Pontes FSC, Gomes CC, Fonseca FP, Pontes ALSC, Uchoa SALC, et al. Assessment of TP53, PTEN and AKT gene mutations in tongue squamous cell carcinoma and oral leukoplakia of smokers and non-smokers. J Oral Diagn [Internet]. 2025 Aug. 22 [cited 2025 Nov. 8];10. Available from: https://joraldiagnosis.com/revista/article/view/337

Issue

Section

Original Article